These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 36919890)
1. Time to surgery does not affect oncologic outcomes in locally advanced gastric cancer after neoadjuvant chemotherapy: a meta-analysis. Liu Z; Zhang Z; Liu H; Chen J Future Oncol; 2023 Feb; 19(5):397-408. PubMed ID: 36919890 [No Abstract] [Full Text] [Related]
2. Optimal timing of surgery for gastric cancer after neoadjuvant chemotherapy: a systematic review and meta-analysis. Ling Q; Huang ST; Yu TH; Liu HL; Zhao LY; Chen XL; Liu K; Chen XZ; Yang K; Hu JK; Zhang WH World J Surg Oncol; 2023 Dec; 21(1):377. PubMed ID: 38037067 [TBL] [Abstract][Full Text] [Related]
3. [Safety and effectiveness of oxaliplatin combined with capecitabine or oxaliplatin combined with S-1 neoadjuvant chemotherapy in the treatment of advanced gastric cancer]. Xie BW; Zang L; Ma JJ; Sun J; Yang X; Wang ML; Lu AG; Hu WG; Zheng MH Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Feb; 24(2):138-144. PubMed ID: 33508919 [No Abstract] [Full Text] [Related]
4. The protocol of a prospective, multicenter, randomized, controlled phase III study evaluating different cycles of oxaliplatin combined with S-1 (SOX) as neoadjuvant chemotherapy for patients with locally advanced gastric cancer: RESONANCE-II trial. Wang X; Li S; Sun Y; Li K; Shen X; Xue Y; Liang P; Li G; Chen L; Zhao Q; Li G; Fu W; Liang H; Xin H; Suo J; Fang X; Zheng Z; Xu Z; Chen H; Zhou Y; He Y; Huang H; Zhu L; Yang K; Ji J; Ye Y; Zhang Z; Li F; Wang X; Tian Y; Park S; Chen L BMC Cancer; 2021 Jan; 21(1):20. PubMed ID: 33402102 [TBL] [Abstract][Full Text] [Related]
5. [Neoadjuvant chemotherapy in advanced stomach cancer--a case of complete response]. Káposztás Z; Cseke L; Kalmár K; Horváth OP Magy Seb; 2002 Oct; 55(5):321-4. PubMed ID: 12474518 [TBL] [Abstract][Full Text] [Related]
6. [Efficacy of neoadjuvant chemotherpy in patients with locally advanced gastric cancer]. Wang Y; Liu TS; Zhuang RY; Cui YH; Wang ZM; Yu YY; Hou J; Sun YH; Shen KT; Shen ZB Zhonghua Wei Chang Wai Ke Za Zhi; 2013 Feb; 16(2):166-9. PubMed ID: 23446480 [TBL] [Abstract][Full Text] [Related]
7. The optimal neoadjuvant chemotherapy regimen for locally advanced gastric and gastroesophageal junction adenocarcinoma: a systematic review and Bayesian network meta-analysis. Wang T; Li C; Li X; Zhai J; Wang S; Shen L Eur J Med Res; 2022 Nov; 27(1):239. PubMed ID: 36352476 [TBL] [Abstract][Full Text] [Related]
8. [Thinking of the application of membrane anatomy in gastric cancer surgery after neoadjuvant therapy]. Zhao DB; Zhang XJ Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Jul; 23(7):657-660. PubMed ID: 32683826 [TBL] [Abstract][Full Text] [Related]
9. Interval time between neoadjuvant chemotherapy and surgery in advanced gastric cancer doesn't affect outcome: A meta analysis. Zhai Y; Zheng Z; Deng W; Yin J; Bai Z; Liu X; Zhang J; Zhang Z Front Surg; 2022; 9():1047456. PubMed ID: 36726960 [TBL] [Abstract][Full Text] [Related]
10. [Prognostic analysis of neoadjuvant chemotherapy for locally advanced gastric cancer with propensity score matching method]. Peng L; Yang W; Zhang Z; Zhi C; Zhou X; Liu H; Hua Y Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Oct; 21(10):1148-1153. PubMed ID: 30370514 [TBL] [Abstract][Full Text] [Related]
11. A phase II trial of neoadjuvant cisplatin-fluorouracil followed by postoperative intraperitoneal floxuridine-leucovorin in patients with locally advanced gastric cancer. Brenner B; Shah MA; Karpeh MS; Gonen M; Brennan MF; Coit DG; Klimstra DS; Tang LH; Kelsen DP Ann Oncol; 2006 Sep; 17(9):1404-11. PubMed ID: 16788003 [TBL] [Abstract][Full Text] [Related]
13. A phase II study of neoadjuvant combination chemotherapy with docetaxel, cisplatin, and S-1 for locally advanced resectable gastric cancer: nucleotide excision repair (NER) as potential chemoresistance marker. Hirakawa M; Sato Y; Ohnuma H; Takayama T; Sagawa T; Nobuoka T; Harada K; Miyamoto H; Sato Y; Takahashi Y; Katsuki S; Hirayama M; Takahashi M; Ono M; Maeda M; Takada K; Hayashi T; Sato T; Miyanishi K; Takimoto R; Kobune M; Hirata K; Kato J Cancer Chemother Pharmacol; 2013 Mar; 71(3):789-97. PubMed ID: 23338051 [TBL] [Abstract][Full Text] [Related]
14. [Safety and efficacy of laparoscopic surgery in locally advanced gastric cancer patients with neoadjuvant chemotherapy combined with immunotherapy]. Lv JB; Yin YP; Zhang P; Cai M; Chen JH; Li W; Li G; Wang Z; Wang GB; Tao KX Zhonghua Wei Chang Wai Ke Za Zhi; 2023 Jan; 26(1):84-92. PubMed ID: 36650004 [No Abstract] [Full Text] [Related]
15. Effect of neoadjuvant chemotherapy on postoperative morbidity and mortality in patients with locally advanced gastric cancer. Ahn HS; Jeong SH; Son YG; Lee HJ; Im SA; Bang YJ; Kim HH; Yang HK Br J Surg; 2014 Nov; 101(12):1560-5. PubMed ID: 25200278 [TBL] [Abstract][Full Text] [Related]
16. Neoadjuvant chemotherapy in locally advanced colon cancer: a systematic review and meta-analysis. Gosavi R; Chia C; Michael M; Heriot AG; Warrier SK; Kong JC Int J Colorectal Dis; 2021 Oct; 36(10):2063-2070. PubMed ID: 33945007 [TBL] [Abstract][Full Text] [Related]
18. Effectiveness of 5-flurouracil-based neoadjuvant chemotherapy in locally-advanced gastric/gastroesophageal cancer: a meta-analysis. Ge L; Wang HJ; Yin D; Lei C; Zhu JF; Cai XH; Zhang GQ World J Gastroenterol; 2012 Dec; 18(48):7384-93. PubMed ID: 23326149 [TBL] [Abstract][Full Text] [Related]
19. [Neoadjuvant chemotherapy for locally advanced gastric cancer]. Kalmár K; Cseke L; Káposztás Z; Horváth G; Varga E Magy Seb; 2003 Oct; 56(5):177-84. PubMed ID: 15022621 [TBL] [Abstract][Full Text] [Related]
20. [Survival analysis of gastric cancer cases with pathological complete response received neoadjuvant chemotherapy]. Zhang Y; Peng Z; Chen L Zhonghua Yi Xue Za Zhi; 2016 May; 96(20):1582-4. PubMed ID: 27266687 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]